amazing how much effort GSK is now putting into boosting production of Relenza.
An Australian Company deriving 7% of sales from a product in demand worldwide. It is being under estimated by the market in my opinion
- Forums
- ASX - By Stock
- glaxosmithkline update: influenza a (h1n1)
amazing how much effort GSK is now putting into boosting...
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online